Research in Surgery

The group is currently reorienting its research priorities in order to gather them around three fundamental research lines in oral and maxillofacial pathology: new technologies, regenerative medicine and molecular biology of cancer. Clinical trials also hold great potential for the group. One of such trials, MR308-3501, focused on the improvement of opioid painkillers, achieved very good results and paved the way for new clinical trials in the maxillofacial area.

We are working on the best way to undertake the clinical aspects of the study on the effect of dietary palmitic acid on metastasis development in patients suffering from a head and neck carcinoma. Previous basic research, undertaken in collaboration with Dr. Salvador Aznar’s group (IRB Barcelona), achieved outstanding results (Nature, 2017) and was widely circulated from a scientific, medical and social point of view. Right now, new dissemination activities for this research are being carried out, while exploring new paths for cooperation.

We have also been working on making the children’s maxillofacial surgery area grow. Among other aspects, a new researcher will be joining the group to work on the analysis of the growth and formation of the upper maxilla in patients with a cleft palate treated using modified presurgical Maxillary Functional Orthopedia.